Introduction
A rticular cartilage has a low intrinsic capacity for repair 1 with the repair response being impeded by a lack of integration of the repair tissue with the surrounding native cartilage. It is well established that wounding of articular cartilage leads to apoptotic and necrotic cell death at the lesion edge [2] [3] [4] [5] [6] [7] ; thus, cartilage tissue integration is likely impaired by a lack of live or viable cells at the interface region that are capable of producing a functional repair tissue. 8, 9 In addition, this is hindered by the inherent limited ability of chondrocytes to migrate through the extracellular matrix toward the acellular interface region. 9 Because surgical repair of cartilage lesions often requires debridement and=or reshaping of cartilage, associated chondrocyte death at the wound edges will be an inevitable problem. Historically, it has been reported that there is a distinct lack of integration of repair tissue with the surrounding host cartilage, with formation of chondrocyte clusters adjacent to zones of cartilage necrosis. 10 Reindal et al. found that if bovine articular cartilage explants were cultured in partial apposition, an increase in adhesive strength was observed and that this was dependent on the presence of viable chondrocytes, and thus active cellular metabolism. 11 Therefore, it is generally accepted that increasing the number of viable chondrocytes at the wound edge will promote tissue integration. 4, 8, 9, [11] [12] [13] Indeed, a number of studies have shown that enzymatic treatment increases cell density at the wound edges of cartilage explants and enhances integrative repair. 9, 12, 13 Interestingly, recent studies have shown that short-term intra-articular administration of a potent caspase inhibitor (Z-VAD-FMK, ZVF) results in a decrease in chondrocyte apoptosis and subsequently less cartilage degeneration after experimental osteochondral injury in rabbits. 14 Further, the use of apoptosis inhibitors in vivo reduced the number of cells undergoing apoptosis in cartilage that had been prepared for surgery, leading to the conclusions that cell death inhibitors could improve the results of cartilage repair surgery. 15 In the light of these findings, we hypothesized that inhibition of the cell death that occurs as a response to wounding of articular cartilage will result in enhanced cartilage integrative repair.
Materials and Methods

Materials
All chemicals were from Sigma (Poole, United Kingdom) unless otherwise stated, and were of analytical grade or above. Culture medium consisted of Dulbecco's modified Eagle's medium (1:1 mixture of DMEM-Glutamax-IÔ and Hams F12 media) containing 10 mM HEPES pH 7.4, 100 U=mL penicillin, 100 mg=mL streptomycin, and 50 mg=mL ascorbate-2-phosphate, and supplemented with 1Â insulintransferrin-sodium selenite (Invitrogen, Paisley, United Kingdom). Insulin-transferrin-sodium selenite supplementation enables chondrocytes to maintain metabolism in serum-free conditions without loss of their normal phenotype as well as preventing activation of stress signaling pathways that occurs on the withdrawal of serum from culture media. 16 Disc=ring composite preparation and culture Articular cartilage from the metacarpophalangeal joint of immature bovine steers, in the form of circular explants, was used to simulate cartilage-cartilage integration in this study. For each experiment, cartilage was taken from a minimum of four legs and randomly assigned to a treatment group. Fulldepth cartilage discs (mean depth 2.3 mm AE 0.4 mm) were cut using a 6-mm-diameter biopsy punch (Steifel, Maidenhead, United Kingdom), removed from the joint, and cultured for 48 h in culture media at 378C in a humidified atmosphere of 5% CO 2 -95% air to establish baseline conditions. After this pretreatment period, the 6 mm cartilage discs were preincubated for 3 h in media containing inhibitors of cell death. Necrostatin-1 (Nec-1; 30 mM; Biomol, Exeter, United Kingdom) was chosen as an inhibitor of necroptosis a necrosis-like cell death pathway. This mechanism of cell death is triggered by the same stimuli that activates apoptosis and is programmed to occur as a backup mechanism to eliminate damaged cells when apoptosis cannot occur.
17 ZVF (20 mM) was chosen as a cell permeable, irreversible pan-caspase inhibitor. Additional studies used Z-IETD-FMK (ZIF; 30 mM) as a cell permeable, irreversible caspase-8 inhibitor 18 and Z-LEHD-FMK (ZLF; 30 mM) as a cell permeable, irreversible caspase-9 inhibitor. 19 Control discs were incubated in media containing 0.2% (vol=vol) DMSO, the solvent used to solubilize the inhibitors. At the end of this period, a 3 mm inner disc was cut using a biopsy punch (Steifel) and left in situ, thus providing an in vitro model to study the effect of wound-induced cell death on cartilage-cartilage integration (Fig. 1) . Cartilage disc=ring composites were cultured for 3 days (gene expression analysis) or 2-6 weeks (cell death= matrix analysis and mechanical testing) in media containing the inhibitors (n ! 3) with cultures being fed with fresh media and inhibitors every 2-3 days unless stated otherwise. DMSO (0.2%) was added to cultures not receiving cell death inhibitors. Disc=ring composites (þ=À inhibitors) were compared to 6 mm cartilage discs.
Analysis of cell death
Determination of necrotic cell death. Primary and secondary necrotic cell death was assessed using the CytoTox
96
Ò assay according to manufacturer's instructions (Promega, Southampton, United Kingdom). This assay quantitatively measures lactate dehydrogenase (LDH) present in the culture media that has been released upon natural lysis of cells during the culture period. 20 Differences in the release of LDH associated with culture treatment were expressed as absorbance units.
Determination of apoptotic cell death. To assess the extent of apoptotic cell death, cartilage was removed from the medium, washed in phosphate-buffered saline (PBS), and fixed in 70% (vol=vol) ethanol for 12 h at 48C. Disc=ring composites were processed by wax embedding and cut into 8 mm sections. Sections were de-waxed, rehydrated, and analyzed using the fluorescent version of the FragELÔ DNA Fragmentation Detection Kit according to manufacturer's in-FIG. 1. Disc=ring model to study cartilage-cartilage integration. (A) Full-depth articular cartilage discs (6 mm) were taken from the metacarpophalangeal joint of 7-day-old bovine calves, washed in medium, and cultured for 48 h at 378C. After 48 h, discs were incubated for 3 h in media with and without (þ=À) inhibitors of cell death. At the end of this period, a 3 mm inner disc was cut and left in situ, thereby creating disc=ring composites to study cartilage-cartilage integration. Composites were cultured for up to 6 weeks in media þ=À inhibitors (n ! 3 per treatment) with cultures being fed with fresh inhibitors every 2-3 days. (B) Description of treatment groups used in the study. structions (Calbiochem, Nottingham, United Kingdom). This assay is a nonisotopic system for fluorescein labeling of DNA breaks in apoptotic nuclei. The total cell population can be visualized using a DAPI filter, thus allowing the percentage of apoptotic cells to be calculated. Detection and analysis of labeling was by fluorescence microscopy (Olympus).
Analysis of proteoglycan release
The total amount of sulfated glycosaminoglycan (sGAG) released into the culture medium over 2 weeks was measured using a modification of the 1,9-dimethylmethylene blue dye binding (DMMB) assay using chondroitin-4-sulfate-C from shark cartilage as a standard. 21 Differences in the release of sGAG associated with culture treatment were expressed as mg of GAG per mL of media.
Histological and immunohistological analysis of cartilage composites
Sections (see the section Determination of apoptotic cell death) were de-waxed, rehydrated, and stained with a 0.1% aqueous solution of toluidine blue to show the distribution of glycosaminoglycans in the cartilage. Sections (two per zone for each treatment) were chosen randomly from within the superficial, mid, and deep zone and scored for the amount of integration. This was assessed under high magnification, as new tissue growth between the two cut surfaces, and expressed as a percentage of the total cut surface. Cartilagecartilage integration was also assessed by immunohistochemistry. Briefly, sections were de-waxed, rehydrated, and washed extensively in PBS before blocking in 2% (vol=vol) normal goat serum for 1 h at room temperature. Sections were incubated overnight at 48C with a mouse monoclonal antibody to type II collagen (CIICI, Hybridoma bank, NIH) diluted in PBS (1:5). Sections were subsequently washed in PBS before being incubated for 1 h at room temperature with a FITC-conjugated anti-mouse secondary antibody diluted 1:100 in PBS. After extensive washing in PBS, sections were mounted in Vectashield Ò Mounting Medium containing DAPI (1.5 mg=mL) to counterstain DNA (Vector Labs, Peterborough, United Kingdom). Labeling was observed using an Olympus BX61 fluorescence microscope.
Scanning and transmission electron microscopy
For scanning electron microscopy (SEM), cartilage was removed from the medium, washed in PBS, fixed in 2.5% glutaraldehyde for 3 h at 48C, and postfixed in 2% osmium tetroxide secondary fixative for 2 h at room temperature. The samples were fully dehydrated using 70-100% graded ethanol, critically point dried, and sputter coated under vacuum in gold. Samples were examined using the Phillips XL-20 scanning electron microscope. For transmission electron microscopy (TEM), cartilage was processed postfixing for ultrastructural analysis 22 and examined using the Philips 208 TEM at 80 kV.
Quantitative PCR analysis of gene expression
Cartilage explants were cultured for 3 days and snap frozen in liquid nitrogen before the addition of 1 mL of Trizol Ò (Invitrogen). Cartilage was powdered in a dismembrator (B. Braun Biotech, Allentown, PA), and total RNA extracted according to the manufacturer's instructions (Invitrogen) but with the following exceptions. After the addition of the chloroform, the whole RNA extraction mix was transferred to a tube containing Heavy Phase-lock GelÔ (Eppendorf Ò , Fisher Scientific, Loughborough, United Kingdom) and centrifuged at 13,000g for 2 min at 48C. The upper aqueous layer was removed to a new Eppendorf Ò tube, an equal volume of isopropanol added, and the RNA left to precipitate overnight at À208C. At the end of the extraction protocol, the RNA was DNase treated to remove genomic DNA (Ambion, Huntingdon, United Kingdom) and resuspended in 50 mL RNasefree water. cDNA was generated in a single 20 mL reaction from 11 mL RNA sample using 250 ng random hexamers (0.5 mg=mL; Promega) and Superscript III reverse transcriptase (200 units; Invitrogen).
Expression of type II collagen was measured by SYBR green quantitative PCR (qPCR) using the MX3000PÔ qPCR system according to manufacturer's instructions (Stratagene Ò ) with 200 nM forward (5 0 -AACGGTGGCTTCCACTTC-3 0 ) and reverse (5 0 -GCAGGAAGGTCATCTGGA-3 0 ) primers. 23 Fold change relative to 6 mm discs were calculated using the DDC T method with 18s ribosomal RNA (5 0 -GCAATTATTCCC CATGAACG-3 0 and 5 0 -GGCCTCACTAAACCATCCAA-3 0 ) as the reference gene. 24 All primers were purchased from Eurofins MWG Operon (London, United Kingdom).
Western blotting
Disc=ring cartilage composites were snap frozen in liquid nitrogen before being powdered in a dismembrator (B. Braun Biotech Int.). Proteoglycans were extracted with 4 M guanidine-HCl for 24 h at 48C, and samples centrifuged at 30,000 g for 15 min at 48C. Pellets were washed with 0.5 M acetic acid before digestion with pepsin (1:10 wet weight) in 0.5 M acetic acid for 24 h at 48C. Samples were centrifuged at 30,000 g for 15 min at 48C, and the supernatant containing pepsin-soluble collagen was analyzed by hydroxyproline assay 25 before Western blot analysis. An equal amount of collagen from control (untreated) and ZVF-treated samples were diluted 1:1 in sample buffer (0. ) diluted in TBST. Membranes were washed and incubated for 1 h at room temperature in appropriate horseradish peroxidase-conjugated IgG. Bands were detected using enhanced chemiluminescence reagents using multiple sheets of Hyperfilm-ECL (GE Healthcare, Little Chalfont, United Kingdom), and various exposure times to ensure samples were within the linear range. 26 Blots were scanned (Umax Magic scan) and analyzed by densitometry (NIH Image).
Mechanical testing
Disc=ring composites were treated with ZVF for 4-days and cultured for a total of 6 weeks. Adhesive properties of the disc=ring interface after 6 weeks in culture were assessed using a push-out test. Thickness of the sample was measured using calipers. A custom-made mechanical testing device in which a push-out rod displaced the disc from the ring (at a rate of 1Â10 À18 N=mm 2 =s) was used to test the adhesive strength with a Lloyd LRX material testing machine (Lloyds Instruments, Hants, UK). A computer-activated micro-stepper controlled the displacement of the push-out rod, while a load cell (100 N) coupled to the rod measured the push-out force. The adhesive strength was calculated from the maximum force measured at failure per unit of interfacial area.
Statistical analysis
Where appropriate, data are presented as mean AE SEM (n ! 3 replicates per treatment) and tested for normality and equal variances before parametric analysis (Minitab).
Results
Effect of Nec-1 and ZVF on chondrocyte death
Analysis of necrotic cell death. Significant differences were observed in the extent of LDH release into the media during the first 48 h of culture representing primary and secondary necrosis (one-way ANOVA, p < 0.001; Fig. 2A ). Establishing the disc=ring composites resulted in a significant increase in LDH release (Fisher's post hoc test; p < 0.001). Treatment of disc=ring composites with ZVF significantly reduced the extent of necrosis that occurred within 48 h of wounding (Fisher's post hoc test; p < 0.001) so that necrosis levels were not significantly different to levels in the 6 mm discs. Nec-1 reduced LDH release when compared to control (untreated) disc=ring composites (Fisher's post hoc test; p < 0.01), but levels were still significantly higher than the 6 mm discs (Fisher's post hoc test; p < 0.01). Similar trends were observed over the first 7 days in culture after which negligible LDH release occurred in all cultures (data not shown).
Analysis of apoptotic cell death. The effect of wounding on apoptosis and the efficacy of the pan-caspase inhibitor, ZVF, in inhibiting apoptosis was assessed using the FragELÔ DNA Fragmentation Detection Kit (Calbiochem). After 2 weeks of culture, disc=ring composites were sectioned and analyzed for the presence of apoptotic nuclei (Fig.  2B) . In the superficial zone of control (untreated) disc=ring composites, extensive numbers of apoptotic nuclei were detected extending several micrometers from the wound edge of both the inner disc and outer ring. In the mid zone, apoptotic nuclei were present but were more restricted to the wound edge. Treatment with ZVF markedly reduced the number of apoptotic nuclei detected in the superficial and mid zones. Equivalent numbers of apoptotic nuclei were detected in the deep zone of control and ZVF-treated composites (sections not shown).
Effect of Nec-1 and ZVF on the release of proteoglycans
Using the DMMB assay, significant differences were observed in the total amount of sGAG released into the media over 2 weeks (one-way ANOVA, p < 0.05; Fig. 2C ). The level of sGAG released into the media was higher in disc=ring cultures compared to the 6 mm discs (Fisher's post hoc test; p < 0.05). Treatment of disc=ring composites with either of the inhibitors resulted in levels of sGAG in the media that were comparable to the 6 mm discs. (Fig. 3A) . Disc=ring composites that had not been treated with cell death inhibitors consistently showed no signs of integration, whereas enhanced integration was observed in cartilage composites treated with ZVF or Nec-1. The extent of integration was further analyzed by staining sections with toluidine blue for the presence of proteoglycans (Fig. 3B, C) . Little or no integration of wound edges was observed throughout the full depth of control (untreated) disc=ring composites (1.0-5.5% of the total wound edge). In contrast, treatment with ZVF resulted in enhanced integration around the entire cut surface, throughout the full depth of the tissue (61.0-71.0% of the total wound edge). When ZVF-treated composites were analyzed under higher power (Fig. 3C) , areas of complete integration were seen as well as areas of newly forming tissue. Nec-1 treatment improved integration compared to control disc=ring composites but not around the entire cut surface and not throughout the full depth (7.0-34.5% of the total wound edge). Because the use of ZVF to inhibit cell death produced more complete areas of integration and reduced LDH and sGAG release, apoptotic death pathways were targeted for further investigation.
Effect of
Nec-1 and ZVF on cartilage-cartilage integration Disc=ring composites were cultured for 2 weeks in the presence or absence of cell death inhibitors, fixed, embedded in wax, and 8 mm sections assessed for integration by immunolabeling for type II collagen
Targeting of specific caspases
To determine whether specific caspases could be targeted to improve integration, disc=ring composites cultured in the presence of the pan-caspase inhibitor, ZVF, were compared to those treated with the caspase-8 inhibitor, ZIF, or the caspase-9 inhibitor, ZLF. SEM was used to assess the extent of integration at the end of 2 weeks in culture (Fig. 4A) . Control composites showed no signs of integration, whereas almost complete integration of the wound edges was observed in composites treated with the pan-caspase inhibitor, ZVF. Disc=ring composites treated with either ZIF or ZLF showed some areas of integration but not to the same extent as ZVF.
To establish whether integration was occurring throughout the full depth of the cartilage, sections were taken from the superficial, mid, and deep zones and stained with toluidine blue for the presence of proteoglycans (Fig. 4B) . In the superficial zone of control composites, there were some areas where new proteoglycan was forming but also extensive areas of little or no new tissue formation. There were no areas of complete integration. Within the mid zone there were areas of no tissue formation as well as areas where complete wound closure had occurred. Treatment with the caspase-9 inhibitor, ZLF, improved integration in the superficial zone and resulted in areas of complete wound closure, partial infilling of the wound gap, as well as areas of The effect of wounding on apoptosis and the efficacy of the pan-caspase inhibitor, ZVF, in inhibiting apoptosis was assessed using the FragELÔ DNA Fragmentation Detection Kit. Cartilage was cultured for 2 weeks, and sections were analyzed for the presence of apoptotic nuclei. Superficial and mid zone sections are shown. Wound edges (white lines) and inner (3 mm) disc (*) are indicated. The number of apoptotic nuclei in the superficial (SZ), mid, and deep zones were counted, plotted graphically as a percentage of the total number of cells, and compared to 6 mm discs. Scale bars ¼ 100 mm. (C) The amount of sGAG lost into the media over the 2-week culture period was assessed using the DMMB assay. Cartilage composites were cultured in the presence or absence of cell death inhibitors for 2 weeks, and media collected every 2-3 days. Data are plotted as total sGAG AE SEM (mg=mL) and analyzed by one-way ANOVA and Fisher's post hoc test (*p < 0.05; n ¼ 3 per treatment). Color images available online at www.liebertonline.com=ten. little integration. Within the mid zone, there were areas of wound closure and complete tissue integration. Results were similar in composites treated with the caspase-8 inhibitor, ZIF (data not shown). In disc=ring composites treated with the pan-caspase inhibitor, ZVF, integration was observed within the superficial zone, and there were fewer areas of partial proteoglycan infilling and more areas where complete wound closure was apparent. Integration was observed between large areas of the wound edge within the mid zone.
Analysis of extracellular matrix expression and deposition
Quantitative PCR was performed to determine whether inhibiting wound-induced apoptosis with ZVF altered type II collagen mRNA expression (Fig. 5A) . Within 3 days of treatment with ZVF, disc=ring composites exhibited a significant, 9.6-fold increase in the expression of type II collagen mRNA compared to control (untreated) disc=ring composites (Student's two-sample t-test, p < 0.001; Fig. 5A ) and a 5.6-fold increase over the 6 mm discs (Student's two-sample t-test, p < 0.05; Fig. 5A ).
In addition, after 3 weeks in culture, pepsin-soluble collagen was extracted from control and ZVF-treated disc=ring composites, and an equivalent amount of total collagen analyzed for type II collagen quantification by Western blotting (Fig. 5B) . After 3 weeks, there was no significant difference in the amount of type II collagen protein present in the total disc=ring composite (Student's two-sample t-test, p ¼ 0.100, after Johnson's transformation of data).
FIG. 4.
Analysis of integration after targeted caspase inhibition. To determine whether specific caspases could be targeted to improve integration, disc=ring composites were cultured in the presence of the pan-caspase inhibitor, ZVF, the caspase-8 inhibitor, ZIF, or the caspase-9 inhibitor, ZLF. At the end of 2 weeks, cartilage was (A) processed and examined using SEM (top panels, Â50 magnification; bottom panels, Â100 magnification) or (B) fixed, embedded in wax, and 8 mm sections stained with toluidine blue to detect proteoglycans. Sections taken from the superficial and mid zones of cartilage left untreated (top panels), treated with ZLF (mid panels), and treated with ZVF (bottom panels) are shown. Scale bar ¼ 100 mm. Color images available online at www.liebertonline.com=ten.
TEM was used to observe the ultra-structure of the matrix forming between the wound edges of ZVF-treated disc=ring composites (Fig. 5C) . After 2 weeks, a basket-like weave of newly formed collagen fibrils was observed between the wound edges of ZVF-treated cartilage. In some areas, a narrower wound gap was observed.
Mechanical testing
The adhesive strength of the interface material formed after 6 weeks in culture was tested by push-out test (Fig. 6A). A significant difference was detected in the stress-to-failure in ZVF-treated disc=ring composites over control composites (0.333 AE 0.041 N=mm 2 vs. 0.065 AE 0.043 N=mm 2 ) (Student's two-sample t-test, p ¼ 0.003; Fig. 6B ).
Discussion
This study utilized a bovine articular cartilage disc=ring composite model to assess the effects of inhibiting cell death on cartilage-integrated repair. Bovine cartilage has been widely used to investigate cartilage integration and produces FIG. 5. Analysis of type II collagen expression and deposition. (A) RNA from 6 mm discs (n ¼ 4), and untreated (n ¼ 6) or ZVF-treated (n ¼ 5) disc=ring composites was analyzed by quantitative PCR to determine the relative expression of type II collagen. Data are presented as fold change relative to 6 mm discs calculated using the DDC T method with 18s ribosomal RNA as the reference gene and plotted as mean AE SEM (Student's two-sample t-test, ***p < 0.001 and **p < 0.01). (B) Pepsinsoluble collagen was extracted from disc=ring composites cultured for 3 weeks and an equivalent amount of total collagen analyzed for type II collagen by Western blotting. Control and ZVF-treated samples were run on the same gel to allow direct comparisons to be made. Levels of type II collagen are plotted as mean densitometric units AE SEM (n ¼ 4 per treatment; Student's two-sample t-test, p ¼ 0.100). (C) At the end of 2 weeks in culture, cartilage composites were processed for dedicated ultra-structural analysis by TEM. Collagen fibrils were observed between the wound edges of ZVF-treated composites (magnification,Â8000). Narrower wound gaps were observed in some areas (magnification,Â10,000). Arrows indicate the wound edges. a reproducible response upon surgical wounding indicative of early trauma in the joint, thus providing a model system to study the basic mechanisms behind cartilage repair. 12, 27, 28 Given that increasing cell viability at the wound edge aids in the integrative process, 9 we investigated whether inhibition of cell death pathways results in enhanced, integrated cartilage repair. Necrotic and apoptotic cell death pathways were chosen as targets because these have both been shown to be induced by wounding in articular cartilage. 2 An increase in both necrotic and apoptotic cell death was observed after establishment of the disc=ring composites. This is in agreement with recent results showing that experimental wounding of articular cartilage leads to cell death at the lesion edge [2] [3] [4] and thus confirms that our model mimics established models of cartilage wounding with respect to the cell death response. The loss of cell viability that was observed after establishment of the model was significantly reduced by preincubating the cartilage, before cutting the 3 mm disc, with inhibitors of cell death pathways-in particular, ZVF. The fact that ZVF, an apoptosis inhibitor, reduced LDH release, a marker of necrosis, suggests a secondary necrotic response after an initial apoptotic stimulus. This phenomenon may occur in cartilage where in the absence of phagocytosis to remove the dead cells, membrane integrity is lost and the cell disintegrates. 29 In addition to increasing cell death, wounding also increased proteoglycan loss from the cartilage composites that over the culture period could be reduced by incubating the composites with the cell death inhibitors. These data suggest that inhibiting the wound-induced death prevents matrix loss and may contribute to improved integration. In addition, the expression of mRNA for type II collagen, the matrix component most important for mechanical integrity of articular cartilage, was enhanced almost 10-fold by inhibiting cell death. Analysis of type II protein levels showed no significant enhancement over a 3-week period although levels detected in the whole explant were 60% higher. This suggests that either with more time or by sampling only the wound edges, the protein levels may better correlate with the mRNA expression data showing significantly increased type II collagen deposition essential for an effective repair.
In all cases, inhibition of cell death improved cartilage integrative repair with the percentage of contact between wound edges (new tissue formed) being substantially more with each of the inhibitors than that observed in untreated composites. Inhibition of cell death with ZVF, however, consistently produced a more superior integration in that there was a higher percentage of contact around the whole of the wound edge in addition to better integration throughout the full depth of the cartilage. ZVF markedly reduced the number of apoptotic nuclei detected that appeared to coincide with areas of enhanced integration (see Fig. 2B ). Interestingly, where there were higher levels of apoptotic nuclei, integration appeared impeded, supporting a direct relationship between the number of viable cells and successful cartilage-cartilage integration.
Because the use of an apoptotic cell death inhibitor appeared to enhance integration around the wound edge and throughout the depth of the cartilage, over that achieved with inhibition of necrotic-like death pathways, two specific caspases were targeted in an attempt to delineate the apoptosis pathway involved. The caspase-8 inhibitor, ZIF, was chosen as an inhibitor of the death receptor-induced apoptosis pathway, and the caspase-9 inhibitor, ZLF, as an inhibitor of the mitochondrial apoptosis pathway. SEM indicated that while all three caspase inhibitors improved integration compared to that observed in untreated, control composites, the extent of integration was better in ZVFtreated cartilage (ZVF>ZIF>ZLF). The observation that ZLF was less successful in enhancing integration may be due to the fact that this inhibitor induced more necrosis and sGAG loss (data not shown). This finding was supported by histology. Interestingly, toluidine blue staining indicated that while there was evidence of new GAG synthesis between the wound edges of control cartilage, total integration within the superficial zone was impeded. This was in contrast to composites treated with the caspase inhibitors that had areas of complete integration within this zone. This is in keeping with the finding that the majority of wound-induced apoptosis occurs within this zone, which is consistent with previously published data. 2, 7 Thus, inhibiting this death would maintain viable cells close to the wound edge to aid integration, again confirming the close correlation between the number of viable cells and successful integration. The relative effectiveness of the three inhibitors suggests that more than one apoptotic mechanism is activated by wounding, hence the pan-caspase inhibitor, ZVF, being by far the most efficacious in enhancing the repair process.
Ultra-structural analysis of the interfacial material to investigate the integrative repair response in more detail revealed the presence of a basket-like weave of collagen fibrils between the wound edges of ZVF-treated cartilage. The size of the wound gap was variable, with some areas being narrower than others. This observation is consistent with the findings of Moretti et al., who found variable wound gap widths but showed that more mature fibrils were present only within the narrowest of interfacial regions. 27 As a functional test of the integration, push-out testing was used to determine the adhesive strength of the newly formed tissue at the wound edge. After 6 weeks in culture, ZVF significantly enhanced the adhesive strength. Overall, the adhesive strength of the newly formed material was low. The presence of more immature fibrils between the wound edges, not extensively crossing into the surrounding cartilage matrix, may provide an explanation for this. Moretti et al. also showed the presence of small immature collagen fibrils that were not integrated with the adjacent explant matrix in their disc=ring composites and hypothesized that this contributed to the relatively low adhesive strength of the composites. 27 Previous studies have shown that cartilage integration is mediated by collagen deposition 30 and that the deposition of collagen fibrils between the wound edges in ZVF-treated composites would support this. In addition, we hypothesize that this collagen is type II collagen because its expression is increased in disc=ring composites treated with ZVF. An extended culture period will enable the newly formed fibrils to mature by aggregating into larger, banded fibrils and undergoing crosslinking comparable to the endogenous tissue.
This study has shown, for the first time, that by using broad spectrum inhibitors of apoptotic cell death, the extent of cell death at the wound edge can be significantly reduced resulting in enhanced tissue integration in immature tissue in vitro. Further studies are, therefore, clearly warranted to study the use of caspase inhibitors in a wider setting particularly in older tissue as well as in vivo because they may be a good candidate to promote cartilage integration, a process that remains problematical in clinical cartilage repair strategies.
